Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry.
CONCLUSION: The medical HFpEF profile is determined by the underlying comorbidities, sex and age. Comorbidities are highly prevalent in HFpEF patients, especially in elderly HFpEF patients. Despite the lack of evidence, many HFpEF patients receive regular beta-blockers, RAS inhibitors and MRAs, often for the treatment of comorbidities.
PMID: 33439465 [PubMed - as supplied by publisher]
Source: Netherlands Heart Journal - Category: Cardiology Authors: Uijl A, Veenis JF, Brunner-La Rocca HP, van Empel V, Linssen GCM, Asselbergs FW, van der Lee C, Eurlings LWM, Kragten H, Al-Windy NYY, van der Spank A, Koudstaal S, Brugts JJ, Hoes AW Tags: Neth Heart J Source Type: research
More News: Atrial Fibrillation | Beta-Blockers | Cardiology | Heart | Heart Failure | Hypertension | Netherlands Health | Study | Women